Search

Your search keyword '"Schwarz Kathleen"' showing total 1,190 results

Search Constraints

Start Over You searched for: Author "Schwarz Kathleen" Remove constraint Author: "Schwarz Kathleen"
1,190 results on '"Schwarz Kathleen"'

Search Results

201. 500 – Health-Related Quality of Life in Young Children with Hepatitis C Treated with Sofosbuvir and Ribavirin and Sofosbuvir/Ledipasvir

204. 26 - Hepatite

206. Sofosbuvir + Ribavirin for 12 or 24 Weeks Is Safe and Effective in Children 3 to <12 years old with Genotype 2 or Genotype 3 Chronic Hepatitis C Infection

208. Health-related Quality of Life in Pediatric Patients With Chronic Hepatitis B Living in the United States and Canada

210. Prevalence and clinical features of patients with concurrent HBsAg and anti‐HBs: Evaluation of the hepatitis B research network cohort.

215. Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11

216. A Learning Collaborative Approach Increases Specificity of Diagnosis of Acute Liver Failure in Pediatric Patients

217. Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study

218. Analytical “bake-off” of whole genome sequencing quality for the Genome Russia project using a small cohort for autoimmune hepatitis

220. Health Related Quality of Life and Neurocognitive Outcomes in the First Year after Pediatric Acute Liver Failure

221. Neurodevelopmental Outcome of Young Children with Biliary Atresia and Native Liver: Results from the ChiLDReN Study

226. Intrahepatic bile duct primary cilia in biliary atresia

233. FRI312 - Clinical features and natural history of 1154 Alagille syndrome patients: results from the international multicenter GALA study group

235. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American multicenter study.

239. Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection

240. The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection

243. Quantitative Surface Antigen and E Antigen in Children with Chronic Hepatitis B: Results from the Pediatric Cohort Study of the Niddk-Sponsored Hepatitis B Research Network (HBRN)

248. Ascites in Children

250. Children with Chronic Hepatitis B in the United States and Canada

Catalog

Books, media, physical & digital resources